SE420493B - Forfarande for framstellning av nya xantinderivat - Google Patents

Forfarande for framstellning av nya xantinderivat

Info

Publication number
SE420493B
SE420493B SE7514477A SE7514477A SE420493B SE 420493 B SE420493 B SE 420493B SE 7514477 A SE7514477 A SE 7514477A SE 7514477 A SE7514477 A SE 7514477A SE 420493 B SE420493 B SE 420493B
Authority
SE
Sweden
Prior art keywords
procedure
preparing new
xantine
derivatives
xantine derivatives
Prior art date
Application number
SE7514477A
Other languages
English (en)
Swedish (sv)
Other versions
SE7514477L (sv
Inventor
W Konz
R Reichl
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE7514477L publication Critical patent/SE7514477L/xx
Publication of SE420493B publication Critical patent/SE420493B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7514477A 1974-12-21 1975-12-19 Forfarande for framstellning av nya xantinderivat SE420493B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (2)

Publication Number Publication Date
SE7514477L SE7514477L (sv) 1976-06-22
SE420493B true SE420493B (sv) 1981-10-12

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7514477A SE420493B (sv) 1974-12-21 1975-12-19 Forfarande for framstellning av nya xantinderivat

Country Status (31)

Country Link
US (1) US3998953A (fr)
JP (1) JPS5188995A (fr)
AT (1) AT341540B (fr)
AU (1) AU501889B2 (fr)
BE (1) BE836898A (fr)
BG (1) BG25518A3 (fr)
CA (1) CA1036159A (fr)
CH (1) CH628346A5 (fr)
CS (1) CS191289B2 (fr)
DD (1) DD124984A5 (fr)
DE (1) DE2460929A1 (fr)
DK (1) DK137677C (fr)
ES (2) ES443738A1 (fr)
FI (1) FI62089C (fr)
FR (1) FR2294706A1 (fr)
GB (1) GB1517710A (fr)
GR (1) GR59204B (fr)
HU (1) HU174673B (fr)
IE (1) IE43208B1 (fr)
IL (1) IL48697A (fr)
LU (1) LU73972A1 (fr)
NL (1) NL7514837A (fr)
NO (1) NO144928C (fr)
NZ (1) NZ179599A (fr)
PH (1) PH11810A (fr)
PL (1) PL99165B1 (fr)
RO (1) RO68381A (fr)
SE (1) SE420493B (fr)
SU (1) SU603340A3 (fr)
YU (1) YU39004B (fr)
ZA (1) ZA757865B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (fr) * 1997-12-17 1999-06-24 University Of South Florida Antagonistes du recepteur de l'adenosine presentant une bioactivite amelioree
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (fr) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (fr) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
NO144928B (no) 1981-08-31
FI62089B (fi) 1982-07-30
FI62089C (fi) 1982-11-10
JPS5188995A (fr) 1976-08-04
IE43208B1 (en) 1981-01-14
ATA904575A (de) 1977-06-15
IL48697A0 (en) 1976-02-29
NO754317L (fr) 1976-06-22
RO68381A (fr) 1982-02-26
YU39004B (en) 1983-12-31
NZ179599A (en) 1978-03-06
YU323475A (en) 1982-08-31
DK137677C (da) 1978-09-25
ZA757865B (en) 1977-08-31
FI753543A (fr) 1976-06-22
FR2294706B1 (fr) 1978-12-01
NO144928C (no) 1981-12-09
FR2294706A1 (fr) 1976-07-16
AU8754775A (en) 1977-06-23
SU603340A3 (ru) 1978-04-15
GR59204B (en) 1977-11-26
CA1036159A (fr) 1978-08-08
IE43208L (en) 1976-06-21
GB1517710A (en) 1978-07-12
PH11810A (en) 1978-07-10
IL48697A (en) 1979-07-25
ES443738A1 (es) 1977-04-16
BG25518A3 (en) 1978-10-10
NL7514837A (nl) 1976-06-23
DK137677B (da) 1978-04-17
DD124984A5 (fr) 1977-03-23
BE836898A (fr) 1976-06-21
HU174673B (hu) 1980-03-28
AU501889B2 (en) 1979-07-05
US3998953A (en) 1976-12-21
CH628346A5 (de) 1982-02-26
DK571875A (da) 1976-06-22
PL99165B1 (pl) 1978-06-30
DE2460929C2 (fr) 1987-12-17
CS191289B2 (en) 1979-06-29
LU73972A1 (fr) 1977-02-15
ES451457A1 (es) 1977-10-01
AT341540B (de) 1978-02-10
DE2460929A1 (de) 1976-06-24
SE7514477L (sv) 1976-06-22

Similar Documents

Publication Publication Date Title
SE442202B (sv) Analogiforfarande for framstellning av nya cefalosporinderivat
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE420201B (sv) Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE424863B (sv) Analogiforfarande for framstellning av nya isokinolinderivat
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE7505796L (sv) Forfarande for framstellning av nya pyridobensodiazepiner innehallande lekemedel
SE420493B (sv) Forfarande for framstellning av nya xantinderivat
SE422052B (sv) Forfarande for framstellning av vissa angivna 1-fenoxi-2-hydroxi-3-aminofenyl-propylderivat
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE425739B (sv) Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE7506024L (sv) Forfarande for framstellning av nya n(6)-disubstituerade adenosin-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7514477-4

Effective date: 19880923

Format of ref document f/p: F